BL
MDGL icon

Bolton LP’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bolton LP’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,077
Closed -$100K – 121
2014
Q4 		$100K Hold
1,077
– – 0.03% 103
2014
Q3 		$113K Hold
1,077
– – 0.02% 108
2014
Q2 		$154K Hold
1,077
– – 0.02% 117
2014
Q1 		$162K Buy
+1,077
New +$212K 0.04% 152

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bolton LP's MDGL Position: Q1 2015 in Review

Bolton LP sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2015, closing a stake of 1,077 shares — an estimated $100K sold.

Bolton LP first reported a position in MDGL in Q1 2014 and held it in 4 quarters. The position peaked at $162K in Q1 2014. 91 funds tracked by Wall St. Rank hold MDGL as of Q1 2015.

  • Bolton LP reported no remaining Madrigal Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Bolton LP sold 1,077 Madrigal Pharmaceuticals shares in Q1 2015, an estimated $100K.
  • Bolton LP first reported a position in Madrigal Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Bolton LP's Madrigal Pharmaceuticals position peaked at $162K in Q1 2014.
  • 91 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2015.

Based on Bolton LP's 13F filing for Q1 2015, filed 15 May 2015.